INTERNATIONAL PATENT: CARMOT THERAPEUTICS, INC. FILES APPLICATION FOR "HYBRID PEPTIDE COMPOUNDS HAVING A SUBSTITUTED TRYPTOPHAN RESIDUE OR A TERMINAL SUBSTITUENT"

GENEVA, June 25 -- CARMOT THERAPEUTICS, INC. (740 Heinz AvenueBerkeley, CA 94710) filed a patent application (PCT/US2024/059456) for "HYBRID PEPTIDE COMPOUNDS HAVING A SUBSTITUTED TRYPTOPHAN RESIDUE OR A TERMINAL SUBSTITUENT" on Dec 11, 2024. With publication no. WO/2025/128624, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HERDGARDEN, Anne Christina (c/o Genentech, Inc.1 DNA WaySouth San Francisco, CA 94080), KRISHNAN, Shyam (c/o Genentech, Inc.1 DNA WaySouth San Francisco, CA 94080), LEE, Craig (c/o Genentech, Inc.1 D...